USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Global Pharmaceuticals Outlook, 2022
Global Pharmaceuticals Outlook, 2022 Updated Research Available
The Digitalization of the Pharmaceuticals Value Chain is Opening up New Growth Opportunities for Stakeholders
08-Mar-2022
North America
$4,950.00
Special Price $3,712.50 save 25 %
Description
Frost & Sullivan offers an outlook for the global pharmaceuticals market for 2022-2026, including emerging trends and growth opportunities. Prioritizing booster doses over initial dose coverage is negatively impacting the global mitigation of the COVID-19 pandemic, which is resulting in severe implications on health and social and economic well-being and delaying endemicity. The ongoing pandemic has accelerated pharma and biotech companies' transformation, and clinical trial decentralization, data-driven R&D, the digitalization of the supply chain, and outsourcing have taken center stage.
The industry will focus on supply chain resilience and the adoption of innovative technologies to improve efficiency while ensuring that healthcare remains precise, preventive, and outcome-based in the promotion of social and financial inclusion. In 2021, the emphasis was on COVID-19 in terms of drug research and therapy administration; this trend is expected to change by the end of 2022, and oncology and CNS are expected to become leading growth areas for the pharma industry. Value-based care will take center stage and lead to a shift to platform- and data-based drug discovery and development models.
Key Issues Addressed
- What is the size of the global pharmaceuticals industry from 2022 to 2026?
- What are the dynamics around COVID-19 vaccination deployment and the path to endemicity?
- How are advancements such as decentralization, blockchain, and new modalities driving the transformation of the pharmaceuticals value chain?
- What is the current and future therapeutic, R&D, and investment outlook and how is it evolving?
- Which growth opportunities can ecosystem participants leverage in the near future?
Author: Surbhi Gupta
RESEARCH: INFOGRAPHIC
This infographic presents a brief overview of the research, and highlights the key topics discussed in it.Click image to view it in full size
Table of Contents
Key Highlights
Regional Impact of the COVID-19 Pandemic
Top Pharmaceuticals Industry Predictions for 2022
Why Is It Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top Three Strategic Imperatives on the Pharmaceuticals Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Market Segmentation and Scope
Key Trend 1—Strategies to Fight Long COVID-19
Key Trend 2—Data-driven R&D Approach
Key Trend 3—Intense Conflict between Affordability and Access
Key Trend 4—Biologics Driving Manufacturing Capacity and Capability Expansion
Global Pharmaceuticals Industry—R&D Expenditure Outlook
Key Therapeutic Areas Outlook
Biopharmaceuticals’ VC Investments and M&A Outlook
Global GDP Growth
2022 Scenario Analysis—Quarterly Global Growth
Supply Chain Disruptions—Impact Analysis
Sustainability Initiatives—Impact Analysis
Global Pharmaceuticals Industry—Historic Sales and Forecast
Segment Performance—Historic Sales and Forecast
Revenue Forecast by Region
Prediction 1
Prediction 2
Prediction 3
Prediction 4
Prediction 5
Small-molecules Market Snapshot, 2022
Small-molecules Market—Companies to Watch
Biologics Market Snapshot, 2022
Biologics Market—Companies to Watch
Growth Opportunity 1—Innovative Formulation and Delivery Technologies for RNA Therapeutics, 2022
Growth Opportunity 1—Innovative Formulation and Delivery Technologies for RNA Therapeutics, 2022 (continued)
Growth Opportunity 2—Contract Research, Development, and Manufacturing Services to Support Emerging Biopharmaceuticals Companies in Asia-Pacific, 2022
Growth Opportunity 2—Contract Research, Development, and Manufacturing Services to Support Emerging Biopharmaceuticals Companies in Asia-Pacific, 2022 (continued)
Growth Opportunity 3—Digital Therapeutics to Support Evidence-based Treatment and Medication Adherence in the EU, 2022
Growth Opportunity 3—Digital Therapeutics to Support Evidence-based Treatment and Medication Adherence in the EU, 2022 (continued)
Key Concluding Thoughts
Market Definition—Pharmaceuticals and Biotechnology
Your Next Steps
Why Frost, Why Now?
List of Exhibits
Legal Disclaimer
Popular Topics
Key Issues Addressed
- What is the size of the global pharmaceuticals industry from 2022 to 2026
- What are the dynamics around COVID-19 vaccination deployment and the path to endemicity
- How are advancements such as decentralization, blockchain, and new modalities driving the transformation of the pharmaceuticals value chain
- What is the current and future therapeutic, R&D, and investment outlook and how is it evolving
- Which growth opportunities can ecosystem participants leverage in the near future
Author: Surbhi Gupta
| Author | Surbhi Gupta |
|---|---|
| GPS Codes | 9600-B1,9825-B1,9A06-B1,9571-B1,99BF-B1,99C0-B1,99C1-B1,99CB-B1,9568-B1,9611-B1 |
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Keyword 1 | pharmaceuticals market |
| Keyword 2 | Pharmaceuticals Industry Trends |
| Keyword 3 | Pharmaceuticals Outlook |
| Podcast | No |
| WIP Number | PCC8-01-00-00-00 |